SQSTM1 and colorectal carcinoma: In contrast, Zhang et al. [42] demonstrated that SQSTM1/p62 acts as an oncogene in CRC, both in vivo and in vitro, and that the overexpression of SQSTM1/p62 significantly inhibited apoptosis.